Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Frequent mutated B2M, EZH2 , IRF8 , and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

Blood Adv (2021) 5 (19): 3760–3775.

https://doi.org/10.1182/bloodadvances.2021005215

Published: 2021

Includes: Supplemental data

Journal Articles

A novel activating JAK1 mutation in chronic eosinophilic leukemia

William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Fei Yang, Sebastian Fernandez-Pol, Richard Press, James Zehnder, Jeffrey W. Tyner, Jason Gotlib

Blood Adv (2021) 5 (18): 3581–3586.

https://doi.org/10.1182/bloodadvances.2021004237

Published: 2021

Includes: Supplemental data

Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Blood Adv (2021) 5 (16): 3147–3151.

https://doi.org/10.1182/bloodadvances.2021004234

Published: 2021

Includes: Supplemental data

Journal Articles

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

Blood Adv (2021) 5 (16): 3188–3198.

https://doi.org/10.1182/bloodadvances.2020004056

Published: 2021

Includes: Supplemental data

Journal Articles

Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia

Suradej Hongeng, Usanarat Anurathapan, Duantida Songdej, Angsana Phuphuakrat, Kesinee Jongrak, Geoffrey Parsons, Briana Deary, Melissa Bonner, Gabor Veres, Mohammed Asmal

Blood Adv (2021) 5 (13): 2701–2706.

https://doi.org/10.1182/bloodadvances.2020003680

Published: 2021

Journal Articles

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML

Cheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, Yuan-Yeh Kuo, Dung-Chi Wu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Mei-Fang Hou, Yi-Kuang Chuang, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien

Blood Adv (2021) 5 (10): 2456–2466.

https://doi.org/10.1182/bloodadvances.2020003738

Published: 2021

Includes: Supplemental data

Journal Articles

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

Blood Adv (2021) 5 (9): 2294–2304.

https://doi.org/10.1182/bloodadvances.2021004367

Published: 2021

Includes: Supplemental data

Journal Articles

Patients with triple-negative, JAK2 V617F- and CALR -mutated essential thrombocythemia share a unique gene expression signature

Blood Adv (2021) 5 (4): 1059–1068.

https://doi.org/10.1182/bloodadvances.2020003172

Published: 2021

Includes: Supplemental data

Journal Articles

Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes

Anthony M. Hunter, Rami S. Komrokji, Seongseok Yun, Najla Al Ali, Onyee Chan, Jinming Song, Mohammad Hussaini, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Eric Padron, Alan F. List, David A. Sallman

Blood Adv (2021) 5 (4): 1017–1028.

https://doi.org/10.1182/bloodadvances.2020003508

Published: 2021

Includes: Supplemental data

Journal Articles

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Sylvain Mareschal, Anna Palau, Johan Lindberg, Philippe Ruminy, Christer Nilsson, Sofia Bengtzén, Marie Engvall, Anna Eriksson, Anne Neddermeyer, Vinciane Marchand, Monika Jansson, My Björklund, Fabrice Jardin, Mattias Rantalainen, Andreas Lennartsson, Lucia Cavelier, Henrik Grönberg, Sören Lehmann

Blood Adv (2021) 5 (4): 1003–1016.

https://doi.org/10.1182/bloodadvances.2020002517

Published: 2021

Includes: Supplemental data

Journal Articles

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel B. Salit, H. Joachim Deeg, Ryotara Nakamura, Wael Saber

Blood Adv (2020) 4 (21): 5562–5573.

https://doi.org/10.1182/bloodadvances.2020002727

Published: 2020

Includes: Supplemental data

Journal Articles

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing

Fabienne Lucas, Phillip D. Michaels, Dahai Wang, Annette S. Kim

Blood Adv (2020) 4 (18): 4362–4365.

https://doi.org/10.1182/bloodadvances.2020002306

Published: 2020

Includes: Supplemental data

Journal Articles

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data

Ti-Cheng Chang, Kelly M. Haupfear, Jing Yu, Evadnie Rampersaud, Vivien A. Sheehan, Jonathan M. Flanagan, Jane S. Hankins, Mitchell J. Weiss, Gang Wu, Sunitha Vege, Connie M. Westhoff, Stella T. Chou, Yan Zheng

Blood Adv (2020) 4 (18): 4347–4357.

https://doi.org/10.1182/bloodadvances.2020002148

Published: 2020

Includes: Supplemental data

Journal Articles

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Blood Adv (2020) 4 (14): 3391–3404.

https://doi.org/10.1182/bloodadvances.2020001949

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma

Joaquin Martinez-Lopez, Sandy W. Wong, Nina Shah, Natasha Bahri, Kaili Zhou, Ying Sheng, Chiung-Yu Huang, Thomas Martin, Jeffrey Wolf

Blood Adv (2020) 4 (14): 3295–3301.

https://doi.org/10.1182/bloodadvances.2020002037

Published: 2020

Journal Articles

Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis

Holly A. Hill, Xinyue Qi, Preetesh Jain, Krystle Nomie, Yucai Wang, Shouhao Zhou, Michael L. Wang

Blood Adv (2020) 4 (13): 2927–2938.

https://doi.org/10.1182/bloodadvances.2019001350

Published: 2020

Includes: Supplemental data

Journal Articles

Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders

Vanessa Gadoury-Levesque, Lei Dong, Rui Su, Jianjun Chen, Kejian Zhang, Kimberly A. Risma, Rebecca A. Marsh, Miao Sun

Blood Adv (2020) 4 (12): 2578–2594.

https://doi.org/10.1182/bloodadvances.2020001605

Published: 2020

Includes: Supplemental data

Journal Articles

High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential

Lambert Busque, Maxine Sun, Manuel Buscarlet, Sami Ayachi, Yassamin Feroz Zada, Sylvie Provost, Vincent Bourgoin, Luigina Mollica, Marlies Meisel, Reinhard Hinterleitner, Bana Jabri, Marie-Pierre Dubé, Jean-Claude Tardif

Blood Adv (2020) 4 (11): 2430–2438.

https://doi.org/10.1182/bloodadvances.2019000770

Published: 2020

Includes: Supplemental data

Journal Articles

Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma

Rafael Alonso, María-Teresa Cedena, Sandy Wong, Nina Shah, Rafael Ríos-Tamayo, José M. Moraleda, Javier López-Jiménez, Cristina García, Natasha Bahri, Antonio Valeri, Ricardo Sánchez, Luis Collado-Yurrita, Thomas Martin, Jeffrey Wolf, Juan-José Lahuerta, Joaquín Martínez-López

Blood Adv (2020) 4 (10): 2163–2171.

https://doi.org/10.1182/bloodadvances.2020001508

Published: 2020

Journal Articles

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

Blood Adv (2020) 4 (8): 1670–1677.

https://doi.org/10.1182/bloodadvances.2019001156

Published: 2020

Includes: Supplemental data

NARROW

Frequent mutated B2M, EZH2 , IRF8 , and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

A novel activating JAK1 mutation in chronic eosinophilic leukemia

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

Patients with triple-negative, JAK2 V617F- and CALR -mutated essential thrombocythemia share a unique gene expression signature

Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma

Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis

Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders

High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential

Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only